Jan 13 (Reuters) - MITHRA PHARMACEUTICALS SA MITRA.BR :
- MAYNE PHARMA AND MITHRA ANNOUNCE US LAUNCH OF HALOETTE®, A GENERIC VERSION OF NUVARING®
- ACCORDING TO IQVIA, NUVARING® US BRAND AND GENERIC SALES WERE APPROXIMATELY USD 564 MILLION FOR 12 MONTHS ENDED NOVEMBER 2022
- MAYNE PHARMA WILL PAY MITHRA A MILESTONE OF EUR 1.6 MILLION
News: MYX Mithra, Mayne Pharma Announce U.S. Launch Of HALOETTE
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.25 |
Change
-0.150(2.78%) |
Mkt cap ! $426.5M | |||
| Open | High | Low | Value | Volume |
| $5.35 | $5.41 | $5.19 | $1.239M | 231.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $5.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.36 | 1000 | 1 |
View Market Depth
| Last trade - 16.11pm 25/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |